LIFESCI INDEX PARTNERS LLC 4
4 · Novus Therapeutics, Inc. · Filed May 2, 2019
Insider Transaction Report
Form 4
LIFESCI INDEX PARTNERS LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.01 per share
2019-04-30$2.70/sh−200$540→ 1,065,867 total(indirect: See Footnote)
Footnotes (1)
- [F1]The Common Stock is held in the accounts of private investment funds managed by LifeSci Index Partners LLC and may be deemed to be beneficially owned by Paul Yook, a principal of LifeSci Index Partners LLC. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaims being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.